Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Mes

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Biomed Research International|October 28, 2015
Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian CarcinomaG Chene, V Ouellet, K Rahimi, et al.
Oncogenesis|April 5, 2013
Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicityP Wojnarowicz, K Gambaro, M de Ladurantaye, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2007
Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genesP M Wojnarowicz, A Breznan, S L Arcand, et al.
British Journal of Cancer|December 24, 2015
A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancerM Koti, A Siu, I Clément, et al.
British Journal of Cancer|January 20, 2006
Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancerC Le Page, V Ouellet, J Madore, et al.
American Journal of Obstetrics and Gynecology|September 10, 1998
Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control studyB Godard, W D Foulkes, D Provencher, et al.
British Journal of Cancer|October 23, 2008
Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitorsJ-S Diallo, B Betton, N Parent, et al.
Cancer Chemotherapy and Pharmacology|July 20, 2004
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2AV Samouëlian, C M Maugard, M Jolicoeur, et al.
Oncogene|October 20, 2001
Microarray analysis of gene expression mirrors the biology of an ovarian cancer modelP N Tonin, T J Hudson, F Rodier, et al.
Clinical Genetics|September 13, 2006
Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descentK K Oros, P Ghadirian, C M Maugard, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Biomed Research International|October 28, 2015
Expression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian CarcinomaG Chene, V Ouellet, K Rahimi, et al.
Oncogenesis|April 5, 2013
Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicityP Wojnarowicz, K Gambaro, M de Ladurantaye, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2007
Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genesP M Wojnarowicz, A Breznan, S L Arcand, et al.
British Journal of Cancer|December 24, 2015
A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancerM Koti, A Siu, I Clément, et al.
British Journal of Cancer|January 20, 2006
Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancerC Le Page, V Ouellet, J Madore, et al.
American Journal of Obstetrics and Gynecology|September 10, 1998
Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control studyB Godard, W D Foulkes, D Provencher, et al.
British Journal of Cancer|October 23, 2008
Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitorsJ-S Diallo, B Betton, N Parent, et al.
Cancer Chemotherapy and Pharmacology|July 20, 2004
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2AV Samouëlian, C M Maugard, M Jolicoeur, et al.
Oncogene|October 20, 2001
Microarray analysis of gene expression mirrors the biology of an ovarian cancer modelP N Tonin, T J Hudson, F Rodier, et al.
Clinical Genetics|September 13, 2006
Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descentK K Oros, P Ghadirian, C M Maugard, et al.
Pageof 6